Abstract: Transducers, kits, systems, and methods for determining a concentration of an analyte are described. In an embodiment, the transducers include a chromophore; and an enzyme physically associated with the chromophore. In an embodiment, the transducer is configured to catalyze a reaction comprising a plurality of reaction elements. In an embodiment, the plurality of reaction elements comprises one or more reactants including the analyte and one or more products. In an embodiment, an amount of fluorescence emitted from the chromophore is determined by a concentration of a reaction element of the plurality of reaction elements.
Type:
Application
Filed:
April 15, 2021
Publication date:
May 25, 2023
Applicants:
UNIVERSITY OF WASHINGTON, LAMPROGEN, INC.
Inventors:
Daniel T. Chiu, Haobin Chen, Jiangbo Yu
Abstract: The present disclosure provides nanoparticle transducers and methods of use thereof for the detection of analyte concentrations in a fluid. Nanoparticle transducers can comprise a nanoparticle, such as a Pdot, coupled to an enzyme that catalyzes a reaction with the analyte. The nanoparticle transducers further comprise chromophores that emit fluorescence that varies as a function of the concentration of one of the elements of the reaction. The nanoparticle transducer thus changes fluorescence as the analyte concentration changes, transforming analyte concentration values into fluorescence intensities. The measurement of these intensities provides a measurement of the analyte concentration. The nanoparticle transducers are biocompatible, allowing for use in vivo, for the monitoring of analyte blood concentrations such as blood glucose concentrations.
Type:
Application
Filed:
November 23, 2022
Publication date:
March 16, 2023
Applicants:
University of Washington, LAMPROGEN, INC.
Inventors:
Daniel T. Chiu, Jiangbo Yu, Changfeng Wu, Kai Sun
Abstract: The present disclosure provides nanoparticle transducers and methods of use thereof for the detection of analyte concentrations in a fluid. Nanoparticle transducers can comprise a nanoparticle, such as a Pdot, coupled to an enzyme that catalyzes a reaction with the analyte. The nanoparticle transducers further comprise chromophores that emit fluorescence that varies as a function of the concentration of one of the elements of the reaction. The nanoparticle transducer thus changes fluorescence as the analyte concentration changes, transforming analyte concentration values into fluorescence intensities. The measurement of these intensities provides a measurement of the analyte concentration. The nanoparticle transducers are biocompatible, allowing for use in vivo, for the monitoring of analyte blood concentrations such as blood glucose concentrations.
Type:
Grant
Filed:
June 5, 2017
Date of Patent:
January 3, 2023
Assignees:
UNIVERSITY OF WASHINGTON, LAMPROGEN, INC.
Inventors:
Daniel T. Chiu, Jiangbo Yu, Changfeng Wu, Kai Sun